MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

MSD's combination of PD-1 inhibitor Keytruda and experimental LAG-3 inhibitor favezelimab has failed a phase 3 trial in patients with previously treated PD-L1-positive microsatellite stable (MSS) ...

COPENHAGEN - Evaxion A/S (NASDAQ:EVAX) announced Thursday that MSD (tradename of Merck & Co., Inc.) has exercised its option to license Evaxion’s preclinical vaccine candidate EVX-B3 for a cash ...

(Reuters) -Alliance Laundry is targeting a valuation of up to $4.34 billion in its U.S. initial public offering, the commercial laundry equipment maker said on Monday, as the frenzy around first-time ...

MSD exercises its option on vaccine candidate EVX-B3 for a cash payment of $7.5 million, which extend Evaxion’s cash runway to first half of 2027 MSD will assume full responsibility for the further ...

LOUISVILLE, Ky. (WAVE) - Some MSD practice work will impact traffic on Dixie Highway this week. On Saturday, a section of Dixie Highway near Depot and Kosmosdale Lane will be reduced to one lane of ...

BDT & MSD’s Alliance Laundry targets $4.3 billion valuation in US IPO ...

PARKLAND, Fla. — Parkland’s Marjory Stoneman Douglas High School was “placed on secure status as a precautionary measure after law enforcement received a tip about a possible weapon on campus” on ...